What’s New
We share news about new product features, our thoughts on recent developments at MedaSystems or in the industry at large. Scroll down for a chronological view, or jump to posts using the categories to the left.
Scaling Expanded Access: What Pharma Leaders Need to Prepare for Next
As Expanded Access Programs become more global and complex, pharmaceutical companies must rethink how they plan, coordinate, and scale. Explore key insights from industry leaders on supply planning, regulatory challenges, cross-functional collaboration, and the growing role of technology and AI in improving patient access to investigational therapies.
Five Years of MedaSystems: How Expanded Access Is Evolving—and What Comes Next
Expanded Access is evolving from a largely reactive process into a strategic, technology-enabled capability. Five years after MedaSystems was founded, we look at how automation, configurable workflows, real-world data, and emerging AI technologies are shaping the future of Expanded Access programs.
OEAP West 2026 Recap: Expanded Access Enters a New Era of Operational Excellence
The conversations at Operationalize: Expanded Access Programs (OEAP) West in San Francisco made one thing abundantly clear: Expanded Access Programs (EAPs) are no longer viewed as exceptional, one-off initiatives.